No CrossRef data available.
Article contents
Benzodiazepine and Z-drug Prescribing for Elderly People in a General Hospital: A Complete Audit Cycle
Published online by Cambridge University Press: 13 June 2014
Abstract
Background: Use of benzodiazepines and Z-drugs in the elderly is associated with adverse outcomes such as increased risk of falls and fractures and cognitive impairment. We aimed to assess the prescribing practice of benzodiazepine and Z-drugs in those aged over 65 years in a general hospital against evidence based standards and to examine the effects of multidisciplinary feedback, as well as determine the prevalence of usage.
Methods: All case-notes and medication charts of patients over the age of sixty five on surgical and medical wards in Sligo General Hospital (SGH) were retrieved and analysed over a two-day period in 2008. Data was collected in relation to benzodiazepine and Z-drug prescribing. We followed up on this initial data collection by screening discharge summaries at six weeks to assess benzodiazepine and Z-drug prescribing on discharge. Audit results were disseminated together with consensus guidelines on the prescribing of these medications in older adult population to all general practitioners in County Sligo. Educational sessions were held for both doctors and nurses in SGH. The audit cycle was completed by a re-audit of benzodiazepine and Z-drug prescribing six months from original study using identical methods.
Results: We found a high prevalence of benzodiazepine and Z-drug use in original audit, 54% (38/70) of the group audited. The prevalence fell to 46% (32/70) at the re-audit post intervention. This result was not statistically significant. The percentage of patients commenced on benzodiazepine and Z-drugs prior to admission fell from 36% (25/70) at the initial audit to 23% (16/70) at the re-audit.
Conclusion: Prescribing practices were not in keeping with consensus guidelines as highlighted by this relatively basic audit cycle. Multidisciplinary feedback and letters to GPs resulted in some reduction in the number of patients prescribed benzodiazepines and Z-drugs. Ongoing educational strategies aimed at relevant health care workers with regular audit of medication use within the general hospital setting is pertinent to further improve prescribing practice.
- Type
- Clinical Audit
- Information
- Copyright
- Copyright © Cambridge University Press 2012
References
1.Hollister, LE, Müller-Oerlinghausen, B, Rickels, K, Shader, RI. Clinical uses of benzodiazepines. J Clin Psychopharmacol. 1993 12;13(6 Suppl 1):1S–169S.CrossRefGoogle ScholarPubMed
2.Longo, LP, Johnson, B. Addiction: Part 1. Benzodiazepines - side effects, abuse risk and alternatives. Am Fam Physician. 2000 04 1;61(7):2121–8.Google Scholar
3.Nolan, L, O'Malley, K. Patients, prescribing, and benzodiazepines. Eur J Clin Pharmacol. 1988;35(3):225–9.CrossRefGoogle ScholarPubMed
4.Petrovic, M, Mariman, A, Warie, H, Afschrift, M, Pevernagie, D. Is there a rationale for prescription of benzodiazepines in the elderly? Review of the literature. Acta Clin Belg. 2003 01-Feb;58(1):27–36.CrossRefGoogle Scholar
5.Kirby, M, Denihan, A, Bruce, I, Radic, A, Coakley, D, Lawlor, BA. Benzodiazepine use among the elderly in the community. Int J Geriatr Psychiatry. 1999 04;14(4):280–4.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
6.Elliott, RA, Woodward, MC, Oborne, CA. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback. Intern Med J. 2001 12;31(9):529–35CrossRefGoogle ScholarPubMed
7.Hartikainen, S, Lonnroos, E, Louhivuori, K. Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sc. 2007 10;62(10):1172–81.CrossRefGoogle ScholarPubMed
8.Paterniti, S, Dufouil, C, Alperovitch, A. Long-term benzodiazepine use and cognitive decline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol. 2002 06;22(3):285–93.CrossRefGoogle ScholarPubMed
9.Glass, J, Lanctôt, KL, Herrmann, N, Sproule, BA, Busto, UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005 Nov 19;331(7526):1169. Epub 2005 Nov 11.CrossRefGoogle ScholarPubMed
10.Royal College of Psychiatrists. Benzodiazepines: Risks, benefits or dependence: a reevaluation. Royal College of Psychiatrists Council Report CR59, London. 01 1997.Google Scholar
11.National Institute for Health and Clinical Excellence. Anxiety: management of anxiety (panic disorder, with or without agoraphobia and generalised anxiety disorder) in adults in primary, secondary and community care. CG22. London: National Institute for Health and Clinical Excellence. 12 2004. Available at: http://guidance.nice.org.uk/CG22. Accessed Nov 2010.Google Scholar
12.Department of Health and Children. Report of the Benzodiazepine Committee. The Stationary Office, Dublin, 2002.Google Scholar
13.Department of Health and Personal Social Services. Medicines Management Standard (Safe and Secure Handling of Medicines), Northern Ireland. 2006. Available at: www.dhsspsni.gov.uk/medicines_management_06.doc. Accessed Nov 2010.Google Scholar
14.Pimlott, NJ, Hux, JE, Wilson, LM, Kahan, M, Li, C, Rosser, WW. Educating physicians to reduce benzodiazepine use by elderly patients: a randomized controlled trial. CMAJ. 2003; 168(7):835–9.Google ScholarPubMed
15.Jamtvedt, G, Young, JM, Kristoffersen, DT, Thomson O'Brien, MA, Oxman, AD: Audit and feedback: effects on professional practice and health care outcomes. Cohrane Database Syst Rev 2003:CD000259.CrossRefGoogle Scholar